IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 682
NA - Nord America 682
AS - Asia 448
SA - Sud America 43
AF - Africa 26
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 652
IT - Italia 370
SG - Singapore 232
DE - Germania 80
GB - Regno Unito 68
IN - India 51
FI - Finlandia 39
BR - Brasile 34
CN - Cina 30
NL - Olanda 24
HK - Hong Kong 22
JO - Giordania 21
SE - Svezia 20
CA - Canada 19
PK - Pakistan 18
ID - Indonesia 16
ES - Italia 12
FR - Francia 11
SA - Arabia Saudita 11
ZA - Sudafrica 11
RU - Federazione Russa 8
CZ - Repubblica Ceca 7
EG - Egitto 7
LT - Lituania 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
MX - Messico 6
AT - Austria 5
BD - Bangladesh 5
IE - Irlanda 5
IQ - Iraq 5
IR - Iran 5
CY - Cipro 4
JP - Giappone 4
BG - Bulgaria 3
EC - Ecuador 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
RO - Romania 3
UA - Ucraina 3
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PS - Palestinian Territory 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
EE - Estonia 1
EU - Europa 1
NZ - Nuova Zelanda 1
OM - Oman 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
Totale 1.890
Salva come PNG Salva come JPEG
Città #
Singapore 171
Chandler 110
Munich 57
Santa Clara 48
Chicago 43
Ashburn 41
London 40
Turku 28
Milan 27
Lawrence 24
Princeton 24
Rome 19
Catanzaro 17
Amman 13
Carbonia 12
Hong Kong 12
Los Angeles 12
Naples 12
Parma 12
San Nicola Manfredi 12
Helsinki 11
Spezzano della Sila 10
Palermo 9
San Francisco 9
Wilmington 9
Boardman 8
Delhi 8
Irbid 8
New York 8
Cosenza 7
Des Moines 7
Kaunas 7
Madrid 7
Ottawa 7
Afragola 6
Catania 6
Ercolano 6
Riyadh 6
Santo Stefano di Rogliano 6
Sezze 6
São Paulo 6
Brooklyn 5
Cape Town 5
Cardiff 5
Frankfurt am Main 5
Jeddah 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Olomouc 5
Sacramento 5
Seattle 5
Ahmedabad 4
Chennai 4
Hanover 4
Hyderabad 4
Nicosia 4
Oristano 4
Perugia 4
Pune 4
Redmond 4
The Dalles 4
West Jordan 4
Acquaviva delle Fonti 3
Addis Ababa 3
Ajman 3
Atlanta 3
Banyumas 3
Berlin 3
Bristol 3
Castrovillari 3
Charlotte 3
Dallas 3
Decollatura 3
Dubai 3
Faisalabad 3
Islamabad 3
Lima 3
Melbourne 3
Mileto 3
Montreal 3
Noida 3
Oxford 3
Paola 3
Quţūr 3
Redwood City 3
Richmond 3
San Antonio 3
Santo Tirso 3
Shanghai 3
Sofia 3
Toronto 3
Warsaw 3
Washington 3
Waterford 3
6th of October City 2
Agrigento 2
Amsterdam 2
Asyut 2
Augusta 2
Totale 1.096
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 352
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 85
miR-22 suppresses DNA ligase III addiction in multiple myeloma 84
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 78
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 68
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 54
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 53
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 51
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 51
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 51
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 51
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 48
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 48
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 45
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 43
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 40
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 39
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 38
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 37
Mmrf-commpass data integration and analysis for identifying prognostic markers 37
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 36
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 35
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 35
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 34
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 33
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 33
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 31
null 31
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 30
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 30
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 29
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 27
Ethical Perspectives on Pharmacogenomic Profiling 24
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 23
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 23
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 22
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 20
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 19
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 18
The potential role of miRNAs in multiple myeloma therapy 17
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 16
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 15
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 14
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 14
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 13
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 11
The EASY-NET research programme: background, structure, and methodology 9
null 4
Totale 1.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 11 1 2 5 10 5 6 7 6 9 1 0
2021/2022126 3 0 0 22 5 0 4 21 34 15 17 5
2022/2023394 55 25 28 13 45 26 6 25 49 40 55 27
2023/2024476 90 33 42 39 45 71 25 41 10 18 27 35
2024/2025876 75 20 27 37 64 119 64 55 55 21 142 197
2025/202631 31 0 0 0 0 0 0 0 0 0 0 0
Totale 1.999